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Abstract: Recent advances in medical care have significantly improved the survival rate of neonates who suffer a hy-
poxic/ischemic event, before, during, or after birth. These infants are extremely vulnerable to brain injury and are at high 
risk of developing motor and cognitive abnormalities later on in life. The regional distribution of perinatal brain injury 
varies, and depends primarily on; the severity, pattern and type of insult, the metabolic status, and on the gestational age. 
The principal neuropathological substrate that is affected in the premature infant is cerebral white matter. The aim of this article is to re-
examine the current knowledge on the ischemic pathophysiology of all cellular components that comprise the white matter, predict the 
consequences of the long-term neurological outcome, and analyze possible therapeutic strategies. Although oligodendrocytes have long 
been regarded as the hallmark of perinatal white matter injury, axons, astrocytes and microglia, all contribute to the complex pattern of 
brain injury that occurs in this cohort of individuals. It is hoped that a better understanding of the pathophysiology of white matter injury 
and its underlying prognostic factors, may lead to the development of new therapeutic strategies for such a complex and debilitating con-
dition.  
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INTRODUCTION 
 Ischemic injury of preterm infants must be considered a major 
issue in today’s society. The incidence of perinatal stroke has been 
estimated at one in 1600 to 5000 births worldwide [1-3], but its 
occurrence is probably underestimated due to the variability in 
clinical and diagnostic criteria. Infection/inflammation and ische-
mia/reperfusion injuries are the two main mechanisms in the patho-
genesis of Periventricular Leukomalacia (PVL) [4]. There are a 
number of well established risk factors that predispose to perinatal 
brain injury. According to a recent classification, such factors can 
be divided into: maternal disorders (infertility, pre-eclampsia, 
chorioamnionitis, substance abuse), placental disorders (placental 
thrombosis, abruption, infection), blood disorders (polycythemia, 
disseminated intravascular coagulopathy, Protein S and C defi-
ciency, antiphospholipid antibodies), homocysteine and lipid disor-
ders, cardiac disorders (congenital heart disease, patent ductus arte-
riosus, pulmonary valve atresia, cardiac surgery), infectious disor-
ders (meningitis, systemic infection), and other miscellaneous dis-
orders (vascular maldevelopment, arterial dissection, trauma, dehy-
dration, catheterisation) [5]. Major advances in medical treatment 
have led to the survival of almost 90% of low birth weight infants 
[6] but about 10% of them later develop spastic motor deficits [7-
9], and about 20-25% later exhibit cognitive, attentional, behav-
ioural, and/or socialisation defects that significantly impair their 
quality of life [10-12]. PVL is the most common cause of brain 
injury in premature infants [13] and results from a hypoxic/ 
ischemic insult during the high-risk developmental period of 23 to 
32 weeks of gestation [14], and to a lesser extent, as a result of 
germinal matrix intraventricular haemorrhage with asymmetric 
necrosis of the periventricular white matter [15]. The pathogenesis 
of PVL comprises systemic infection and inflammation, and  
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maturation-dependent intrinsic vulnerability of premyelinating oli-
godendrocytes [16]. However, white matter damage in PVL is not 
restricted to oligodendrocytes. Dammam et al. [17] suggested that 
white matter damage due to PVL involves deficits in oligodendro-
glia, loss of axonal fibres, microgliosis, and astriogliosis (Fig. 1). 
OLIGODENDROCYTE INJURY 
 Oligodendrocyte injury has long been regarded as the hallmark 
of PVL. Oligodendrocyte development occurs in four stages: early 
oligodendrocyte progenitor cell (OPC), late OPC (also called pre-
myelinating oligodendrocytes), immature myelinating oligodendro-
cyte, and mature myelinating oligodendrocyte [18]. Back et al. [19] 
reported that late OPC are significantly more vulnerable to ischemia 
than early OPC. This maturation-sensitivity of the late OPC leads to 
preferential white matter injury in the neonate [16] and coincides 
with the high-risk period for PVL in humans [20]. Injury of the late 
OPC is therefore regarded as the main pathological lesion seen in 
cerebral white matter in the neonate [21]. The major factors that 
underlie the maturation-dependent susceptibility of the late OPCs 
are: (i) abundant production of reactive oxygen and nitrogen species 
in combination with delayed development of glutathione antioxi-
dant defences, (ii) acquisition of Fe
2+
, and (iii) exuberant expression 
of the major glutamate receptors (GluRs) (?-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) receptors deficient in 
the GluR2 subunit and of N-methyl-D-aspartate (NMDA) receptors 
(both Ca
2+
-permeable)) [16]. 
 Although the vulnerability of the late OPC is one of the hall-
marks of the increased susceptibility of white matter injury to 
ischemia during development, as we previously reported, the imma-
ture myelinating oligodendrocytes also contribute to the continuum 
of white matter vulnerability following ischemia [22, 23]. Thirty 
minutes of oxygen-glucose deprivation (OGD) is sufficient to kill 
almost 70% of oligodendrocytes, and the percentage of dead 
oligodendrocytes in neonatal mice (P10 - post-natal day 10) is 
significantly higher than that in older age groups (Fig. 2). Since in 
the mouse optic nerve immature myelinating oligodendrocytes  
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Fig. (1). Cellular mechanisms of injury in perinatal white matter ischemia. 
Cartoon depicts the stage-specific mechanisms that are thought to contribute to the heightened sensitivity of all components of white matter injury during the 
perinatal period. 
 
 
 
Fig. (2). Heightened vulnerability of immature myelinating oligodendrocytes to ischaemia. 
Left: Cropped sections from high power micrographs (X60) of optic nerve sections from 3 different age groups (P<20, P20-50, and P>50) immunostained with 
anti-APC (left) and Hoechst stain (right) after 60 mins OGD.  Optic nerves from P <20 mice had a greater number of pyknotic nuclei when compared to older 
age groups. Right: Comparison of the percentage of dead oligodendrocytes following ischemia between different age groups. There was a statistically signifi-
cant difference (*p ? 0.05) in the percentage of dead oligodendrocytes between the different age groups after 30 mins of OGD. APC +ve oligodendrocytes at P 
< 20 were the most vulnerable to injury. (OGD – Oxygen-glucose deprivation; IF – immediately fixed ; 1hr – 1 hour reperfusion; 2hr – 2 hours reperfusion; 3hr 
– 3 hours reperfusion). 
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predominate at around P7 to P10 [20], our results suggest that 
immature myelinating oligodendrocytes are more vulnerable than 
mature myelinating oligodendrocytes. In cell cultures, mature 
oligodendrocytes (A2B5
-
 /GC
+
) are more resistant to ischemia than 
immature ones (O4+/GC-) [24]. Results from these studies suggest 
that rapid ischemic cell death of immature oligodendrocytes is 
mediated by Ca
2+
 influx via non-NMDA glutamate receptors, and 
exacerbated by significant autologous feedback of glutamate from 
cells on their own receptors [24]. 
LOSS OF AXONAL FIBRES 
 The sensitivity of rat grey matter to anoxia and aglycaemia 
increases progressively from birth to adulthood; consistent with the 
rise in metabolic demand of this tissue [25, 26]. However, white 
matter does not follow a similar pattern. After a period of increased 
tolerance to ischemia (P3 mice), Fern et al. [27] reported an in-
creased vulnerability to ischemia of white matter in terms of func-
tional loss of conduction in P20-P50 mice. This vulnerability starts 
to decrease at P50, which is in agreement with our published obser-
vations [22], wherein the degree of ischemia-induced structural 
axonal injury in P20 - P50 mice is significantly higher than in any 
other age group (Fig. 3). 
 In the mouse optic nerve, myelination starts at around P7, with 
few axons having only one whorl of myelin at this age [28]. The 
rate of myelin deposition thereafter peaks at P21-P28, and from this 
point onward, the process of myelination is at its highest [29]. The 
period of low tolerance to ischemia observed [22] in mice between 
P20 and P50 coincides with this process of myelination, and the 
increase in sensitivity to ischemia can be attributed to the onset of 
the associated heightened metabolic activity [30-32]. Fowler et al. 
[33] proposed that myelination might increase axonal vulnerability 
to oligodendrocyte-induced damage, since perturbation of the oli-
godendrocyte-myelin-axon interaction in myelinated white matter 
decreased axonal damage after AMPA administration in rats. Mye-
lination is not the only contributor to this increased vulnerability, as 
Na
+
-channel density in optic nerve axons also varies with age. This 
starts from < 2/?m2 in the neonate [34], increasing up to the age of 
about P25, and declining during adulthood [35]. During myelina-
tion Na
+
 channels aggregate at the nodes of Ranvier, and ischemia 
causes an increase in density and a persistent non-inactivating Na
+
 
current that leads to increased axonal calcium flux through reversal 
of the Na
+
/Ca
+
 exchanger [36].  
 As we previously reported [23], large (> 0.4 ?m in diameter) 
pre-myelinating axons are more sensitive to OGD than smaller pre-
myelinated and myelinating axons. Blockade of NMDA and non-
NMDA GluRs alone provides only partial protection from ischemic 
injury whereas addition of L-type and P/Q-type voltage-gated cal-
cium channel (VGCC) blockers to these GluRs antagonists results 
in complete recovery of the compound action potential [23, 37]. 
Comparison of OGD-induced damage to small (< 0.4 ?m) and to 
large (>0.4 ?m) premyelinating axons shows that the former are 
protected by GluR blockers alone, whilst the latter needs addition of 
VGCC-blockers to confer protection [23]. This study shed light on 
the importance of VGCC in this age group, and on the pathophysi-
ological mechanism of injury during ischemia in these very sensi-
tive axons. 
MICROGLIOSIS 
 Numerous studies have demonstrated that activated microglia 
trigger injury to immature white matter causing injury to surround-
ing neurons and glia through the release of neurotoxins, glutamate, 
reactive oxygen species, nitric oxide and inflammatory cytokines 
[38-40]. Other substances released from microglia, such as tumour 
necrosis factor-? (TNF-?), can increase the susceptibility of sur-
rounding neurons and oligodendrocytes to ischemic injury [41]. It 
was also demonstrated that lipopolysaccharide-activated microglia 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Heightened vulnerability of actively myelinating axons to ischaemia. 
Left: Confocal images (Magnification X 60 lens – X 400 digital zoom) of Thy-1/GFP-M mice from 3 different age groups following 30 mins OGD. There is 
progression of injury in all age groups, but features of axonal damage were first evident in P20-50 mice, followed by P >50 mice, and finally P <20 mice. 
Thick arrows mark axonal swelling; thin arrows mark beading and fragmentation. Right: Comparison of axonal injury following ischemia between different 
age groups. There was a statistically significant difference (*p ? 0.001) in axonal injury score between the different age groups at each time point following 30 
mins of OGD. P20-50 mice (box) were the most vulnerable to injury, and P <20 mice (diamond) were the most resistant. (OGD – Oxygen-glucose deprivation; 
IF – immediately fixed ; 1hr – 1 hour reperfusion; 2hr – 2 hours reperfusion; 3hr – 3 hours reperfusion). 
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adversely affected the survival and development of oligodendrocyte 
progenitor cells, reducing the production of myelin basic protein 
[42]. Therefore, disturbance of myelination in PVL is believed to be 
due to arrested maturation of premyelinating oligodendrocytes in-
duced by nitrosative and oxidative mechanisms mediated by micro-
glial cells [43, 44]. 
 The density of microglia in the brain varies throughout devel-
opment [45]. During the period of high sensitivity of the human 
brain to ischemia, activated microglia are concentrated in the cere-
bral white matter. This maturation-dependent distribution of micro-
glia might also play a role in the selective white matter injury dur-
ing this stage, since microgliosis is a prominent feature of cerebral 
white matter injury seen in premature infants [45]. 
ASTRIOGLIOSIS 
 Astrocytes play a vital role in the normal physiology of the 
human brain. They regulate synaptogenesis, neurotransmission, 
metabolic support, blood-brain barrier formation/maintenance, and 
actively participate in the innate immune response [46-48]. There-
fore, they are likely to be involved in the cascade of pathological 
events that occur in the immature brain in response to infection 
and/or inflammation [46]. Neonatal white matter astrocytes are 
highly susceptible to ischemic injury [49, 50]. This high sensitivity 
is due to an exaggerated Ca
2+
 influx through T-type VGCC [51]. 
Damage to astrocytes causes impairment of astrocyte glutamate 
receptors resulting in the excessive accumulation of extracellular 
glutamate that contributes to the excitotoxic injury of oligodendro-
cytes and axons [52]. It also disrupts the homeostatic and metabolic 
regulation of glucose and lactate, with subsequent failure of energy 
maintenance [53]. Moreover, inhibitory factors released from reac-
tive astrocytes arrest the maturation of late OPCs [54]. 
PREDICTORS OF LONG-TERM NEURODEVELOPMEN-
TAL OUTCOME FOLLOWING NEONATAL ISCHEMIA 
 In the developing immature brain, ischemic brain injury predis-
poses to cerebral palsy, a non-progressive motor disorder of move-
ment and posture, which is often accompanied by disturbances in 
sensation, perception, cognition, communication and behaviour 
[55]. Improved neonatal care within the last decade has lead to the 
increased survival of preterm and low-birth-weight infants. How-
ever, this resulted in an increased risk of adverse long-term out-
comes, especially with respect to cognitive and behavioural deficits 
[56].  
 The age and location of the insult are important determinants 
and predictors of neurodevelopmental outcome. There is consider-
able evidence that an early brain insult is associated with a broad 
spectrum of neuropsychological dysfunction [57, 58]. In fact, the 
onset of stroke at a younger age predisposes to an overall worse 
prognosis [59-61], weaker cognitive performance, and is subject to 
lesion location [62]. Westmacott et al. [62] reported that individuals 
who suffered a subcortical stroke (affecting the thalamus and/or 
basal ganglia axis) before the age of 28 days performed signifi-
cantly poorer in terms of intellectual performance than older chil-
dren with the same insult. In contrast, in the case of cortical strokes, 
the period of greatest vulnerability appears to be within 1 month 
and 5 years. In a more recent study, Studer et al. [63] found that 
cognitive outcome in children who suffered an acute ischemic 
stroke (defined as focal neurological deficit of acute onset con-
firmed by cranial Computed Tomography (CT) or Magnetic Reso-
nance Imaging (MRI) showing an infarction in a corresponding 
location) between 1 month and 3 years was worse than in older 
children. However they did not find any influence of lesion location 
(cortical or subcortical) to the overall outcome. They hypothesized 
that rather than lesion location, lesion size is a more valid predictor 
of overall outcome, since larger lesions disrupt a wider network of 
neural connections, resulting in worse cognitive outcomes. Maitre 
et al. [64] reported a similar finding; infants who suffered unilateral 
periventricular hemorrhagic infarction had better motor and cogni-
tive outcomes than infants with bilateral periventricular hemor-
rhagic infarction. 
 Preterm born very-low-birth-weight (VLBW: birth weight 
<1500g) infants are at an increased risk to develop perinatal brain 
injuries that will ultimately result in abnormal brain development 
[4, 9]. Several studies have investigated the relationship between 
perinatal brain injuries in VLBW survivors and brain development 
[65-67]. In a recent meta-analysis, de Kieviet et al. [68] summa-
rised that VLBW infants who suffer perinatal brain injury develop 
smaller total brain volume with reduced volume of grey and white 
matter. Such injuries may influence cognitive development and 
performance [21, 68]. Aarnoudse-Moens et al. [69] reported a re-
duction in academic achievements and problems with behaviour, 
attention and executive functions in VLBW children that are corre-
lated to the degree of immaturity at birth. A recent study by Bjuland 
et al. [70] investigated the difference in brain volumes and cogni-
tive abilities between VLBW subjects and term born controls. They 
reported a reduction in absolute volumes of several brain structures 
(mainly thalamus, caudate nucleus, cerebellar white matter and 
corpus callosum) with the most immature and smallest VLBW birth 
infants having the most pronounced volume reduction. This de-
crease in brain volume was also correlated with a reduction in IQ 
levels, which suggested that perinatal brain injury associated with 
VLBW induces permanent deficits in cognitive abilities later on in 
life. Taylor et al. [71] also reported a significant correlation be-
tween IQ levels and cerebral white matter volume in VLBW ado-
lescents. 
 Jakobson et al. [72] suggested that deficits in mental capabili-
ties related to premature births are not due to prematurity per se, but 
from complications associated with it. This was further validated by 
Pavlova et al. [73], who reported no difference in mental calcula-
tion scores between term-born and premature-born babies with 
normal MRI findings. However, pre-term infants are prone to vari-
ous complications, including late-onset sepsis [74]. This leads to 
white matter abnormalities later on life [75-77], since the preterm 
brain, in particular white matter, is highly vulnerable to damage by 
inflammation and ischemia [78]. van der Ree et al. [79] investi-
gated the effect of late-onset sepsis in preterm children. The major-
ity of preterm infants who survived the late onset sepsis showed a 
lower intelligence, impaired attention and verbal memory, and an 
abnormal motor outcome at school age (6 to 9 years). Moreover, 
multiple episodes of sepsis result in a worse outcome, possibly due 
to progressive white matter injury following recurrent infections 
[80].  
 Biomarkers have become increasingly utilised as non-invasive 
tools in the early diagnosis of various clinical conditions. Recently, 
Andrikopoulou et al. [81] reviewed some markers that can be used 
as early detectors of perinatal ischemia; indicators that may help in 
predicting the prognosis of such infants. Detection of nucleated red 
blood cells at birth reflects a response of the infant to perinatal hy-
poxia [82] and can be used for the assessment of the severity and 
early outcome after perinatal asphyxia [83]. Glial fibrillary acidic 
protein (GFAP) is a brain-specific cytoskeletal intermediate fila-
ment protein found in astrocytes. Studies have explored the use of 
this marker for the early diagnosis of patients with stroke [84]. En-
nen et al. [85] observed significantly elevated GFAP concentrations 
in blood samples in patients with hypoxic-ischemic encephalopathy 
when compared with controls. Systemic infection is one of the main 
contributing factors to cerebral white matter injury [86], and there-
fore inflammatory cytokines may be useful as markers of the in-
flammatory response post-injury. Ellison et al. [87] found that pre-
term infants with MRI-defined cerebral white matter lesions had 
higher levels of interleukin (IL)-6, IL-10, and TNF-? in their cere-
brospinal fluid, than infants without such findings. Ramaswamy  
et al. [88] reported that serum and cerebrospinal fluid concentra-
tions of IL-1b and IL-6 were predictors of abnormal outcome in 
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patients with hypoxic-ischemic injury. S-100 is a calcium binding 
protein and is a major component of the cytosol in glial cells. Qian 
et al. [89] reported elevated levels of this protein in neonates with 
hypoxic-ischemic encephalopathy. Gazzolo et al. [90] demonstrated 
that a high concentration of S100 had a sensitivity of 91.3% and a 
specificity of 94.6% for predicting the development of hypoxic-
ischemic encephalopathy. 
NEUROIMAGING ASSESSMENT OF PVL 
 Neuroimaging is a widely used tool to assess the severity of 
brain injury following foetal or neonatal ischemia, since the long-
term outcome in such infants depends on the nature of the initial 
insult [91]. Cranial ultrasonography (US) is very useful for the de-
tection of intraventricular hemorrhage and cystic PVL. It is readily 
applied at the bedside, does not involve ionizing radiation, is cost-
effective, and can be used sequentially [92]. Multiple single, and 
multi-centre studies reported an association between cranial US 
findings and adverse neurodevelopmental outcomes [93-95]. The 
strongest predictors of subsequent cerebral palsy visualised on US 
are ventriculomegaly and white matter echolucencies [96]. Applica-
tion of advanced techniques, including the use of high-resolution 
linear transducers and Doppler assessment of intracranial vascula-
ture, assist in maximizing the value of this important tool [97]. 
However, cranial US has its limitations. Brain views are limited to 
what can be seen through the fontanelles [94] and only 30 % of 
white matter injuries are consistently detected with US. These in-
clude areas of necrosis, diffuse gliosis, cystic PVL, and ventricu-
lomegaly due to periventricular white matter loss [98]. Inder et al. 
[99] reported that 55% of infants with a normal cranial US showed 
extensive signal intensity abnormalities or cystic changes in the 
cerebral white matter on Magnetic Resonance Imaging (MRI).  
 Multiple studies [100, 101] reported that MRI findings have a 
higher sensitivity and specificity to predict cerebral palsy when 
compared to cranial US. Woodward et al. [102] found significant 
associations between the qualitative measures of cerebral white- 
and gray-matter abnormalities on MRI, and the subsequent risks of 
adverse neurodevelopmental outcomes at two years of age. In addi-
tion, moderate to severe white matter abnormalities were predictive 
of severe psychomotor delay and cerebral palsy. In a recent study, 
Imamura et al. [103] investigated the relationship between MRI 
findings and neurodevelopmental outcome of children with PVL. 
They graded PVL based on MRI findings [104] as Grade 1, 2 and 3. 
Children with Grade 1 PVL had abnormally high signal intensity in 
the periventricular white matter on T2 and fluid-attenuated inver-
sion recovery images, most commonly observed bilaterally in the 
trigone regions of the lateral ventricles. In Grade 2 PVL there was 
loss of the periventricular white matter in the regions with abnor-
mally high signal intensities, and ventricular enlargement adjacent 
to the regions of the lateral ventricles. In Grade 3 PVL there was 
focal and extensive cystic changes in the white matter. Children 
with Grade 2 and 3 had severe neurodevelopmental delays with a 
high degree of motor impairment and cognitive disability. On the 
other hand, 56 % of infants with Grade 1 PVL had normal psycho-
motor development [103]. 
 Radiologists routinely read clinical MRIs qualitatively. Al-
though this is a useful technique for clinical decision-making, it 
does not provide quantitative values that can be used to monitor 
neurodevelopmental progress. Recent advances in MR imaging 
modalities provide new tools for researches to assess quantitatively 
injury to brain structures. MR Diffusion tensor imaging is widely 
accepted for use in paediatric studies [105]. Using this technique on 
PVL patients, Wang et al. [106] reported a significant reduction in 
mean fractional anisotropy (FA) value (sensitive to axon size, den-
sity, organisation and degree of myelination) in a number of white 
matter tracts (corticospinal tract, internal capsule, arcuate fascicu-
lus, posterior thalamic radiation, corona radiate, superior longitudi-
nal fasciculus, and splenium of corpus callosum). These subjects 
also showed various degree of cognitive and motor impairment. 
Cognitive functions are supported by a network of multiple inter-
connected cortical and subcortical regions, and the integrity of the 
connecting white matter is an essential tool for efficient cognitive 
processing [107]. Since there is a correlation between the FA value 
and cognitive function in terms of IQ score [108], Wang et al. [106] 
demonstrated that the disturbance of the cognitive ability in preterm 
children with PVL was significantly correlated to the disruption of 
white matter microstructure in widespread areas of the brain. 
CURRENT AND FUTURE THERAPEUTIC APPROACH  
 To date, there is no known effective treatment for PVL. Apart 
from therapeutic hypothermia [109, 110], none of the proposed 
experimentally neuroprotective treatments have managed to find 
their places in standard clinical practice [111]. However, continu-
ous research is being done to develop new therapeutic regimens to 
treat or prevent the development of PVL.  
 Glutamate excitotoxicity is a main factor in the pathophysiol-
ogy of hypoxia-ischemia in the neonate. Magnesium is an NMDA 
receptor antagonist, and prevents neuronal influx of Ca
2+
. The use 
of magnesium in clinical trials has produced conflicting results. 
One trial showed some neuroprotective benefit in term infants with 
severe asphyxia [112]. In another, Rouse et al. [113] reported a 
non-significant reduction in stillbirth or death in one year, but a 
statistical significant reduction in moderate to severe cerebral palsy. 
Anticonvulsant drugs, like memantine and topiramate also reduce 
glutamate toxicity by blocking NMDA and AMPA receptors re-
spectively. These drugs were found to be highly effective in reduc-
ing brain injury following hypoxia/ischemia [114, 115]. Erythro-
poietin inhibits apoptosis, neuronal excitotoxicity, and inflamma-
tion. Infants with neonatal encephalopathy treated with this drug 
displayed a significant reduction in terms of mortality and disability 
[116].  
 Since reactive oxygen species are one of the hallmarks of peri-
natal ischemic injury, free radical scavengers have also been tested 
as possible therapeutic strategies. Antenatal administration of al-
lopurinol was found to reduce the degree of hypoxic-ischemic en-
cephalopathy in neonates exposed to foetal hypoxia [117]. Other 
anti-oxidants such as 2-iminobiotic and indomethacin were also 
found to be effective [118]. Antioxidant enzymes administrated 
prophylactically during pregnancy reduced neuronal injury in rat 
pups subjected to hypoxia-ischemia [119]. Vitamin K has been 
shown to prevent oxidative injury to undifferentiated oligodendro-
cytes [120], but to date no clinical trials have been done to evaluate 
its potential to decrease inflammatory or ischemic injury during 
perinatal ischemia. 
 The role of pro-inflammatory cytokines in the pathophysiologi-
cal cascade leading to neonatal brain damage is increasingly recog-
nized. Postnatal systemic administration of Interleukin-1 receptor 
antagonist was found to preserve motor function and exploratory 
behaviour in rats following exposure to inflammation and/or post-
natal hypoxia-ischemia [121].  
 In recent years, stem cell treatment has generated interest in 
many medical fields, particularly in conditions with irreversible 
organ damage and non-available specific treatment. Animal studies 
support the idea that cord blood and mesenchymal stem cells have a 
therapeutic effect in neonatal hypoxic-ischemic encephalopathy 
[122]. These effects have been attributed to immunomodulation, 
activation of endogenous stem cells, release of growth factors, and 
anti-apoptosis mechanisms [123]. Intranasal administration of mes-
enchyme stem cells in neonatal mice, reduced the brain lesion vol-
ume induced by hypoxia/ischemia and improved their motor and 
cognitive behaviour [124]. In a currently ongoing Phase I clinical 
trial, Mancías-Guerra et al. [125] are assessing the safety, tolerabil-
ity and efficiency of bone marrow-derived total nucleated cells, in 
patients diagnosed with cerebral palsy. Their preliminary results are 
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promising, with good safety results and improvement in neurologi-
cal function. 
CONCLUSION 
 Cerebral white matter injury following a hypoxic or ischemic 
insult during the neonatal period can lead to severe disability later 
on in life, both in terms of motor disorders and cognitive impair-
ment. The nature of this condition is such that it does not only af-
fect the patients. Its ramifications cause considerable burden upon 
the people closest to them and to society in general. Better under-
standing of the pathophysiology of this condition might give new 
insights in developing new therapeutic modalities for such a chal-
lenging disease. Moreover, identifying crucial prognostic factors 
that determine long-term neurodevelopment outcomes may possibly 
help identify individuals at risk. Such patients would benefit from 
proper rehabilitative care and better assistance throughout the early 
stages of development, thereby ameliorating their quality of life. 
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